← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 2010First marketed drug
May 27, 2015First NDA
May 27, 2015Last known activity
May 1, 2012
Acquired by Forest Laboratories → Actavis → Allergan PLC (2015) → AbbVie on Jul 3, 2014
Timeline
1990s
- Jan 1, 1998
Furiex— Founded
2010s
- Jul 3, 2014
Forest Laboratories— Acquired By
- May 27, 2015
eluxadoline— NDA Organization
- Jun 26, 2019
AbbVie— Now
Drugs by trial phase (6 distinct, 6 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Indications
Approved for
Marketed drugs (1)
Recent trials (6)
- NCT01553591Lead sponsorPhase 3May 1, 2012
- NCT01553747Lead sponsorPhase 3May 1, 2012
- NCT01279590Lead sponsorPhase 2Mar 1, 2011
- NCT01198626Lead sponsorPhase 2Oct 1, 2010
- NCT01128530Lead sponsorPhase 2Jun 1, 2010
- NCT01130272Lead sponsorPhase 2May 1, 2010
Details
- Founded
- Morrisville, NC, US Jan 1, 1998
- First NDA
- May 27, 2015
- Last known activity
- May 1, 2012
Designations held
- Fast track
- Priority review